Glucocorticoid therapy in hyperandrogenism.

Area of Science:

• Endocrinology
• Reproductive Medicine
• Dermatology

Background:

• Hyperandrogenism is a common endocrine disorder in reproductive-aged females.
• It presents with cutaneous manifestations and ovulatory dysfunction, often leading to infertility.
• Idiopathic glucocorticoid-suppressible hyperandrogenism (IGSH) is the most frequent form.

Purpose of the Study:

• To investigate the efficacy of glucocorticoid therapy in managing hyperandrogenism and its associated symptoms.
• To evaluate the impact of glucocorticoid treatment on ovulatory function and fertility in women with IGSH.
• To assess the long-term effects and safety of glucocorticoid therapy for IGSH.

Main Methods:

• Management of IGSH using physiological doses of glucocorticoids.
• Monitoring of serum androgen levels, cutaneous symptoms, and ovulatory function.
• Assessment of pregnancy rates in relation to androgen suppression levels.

Main Results:

• Glucocorticoid therapy normalized serum androgen levels, improved cutaneous symptoms, and enhanced ovulatory function.
• Pregnancy occurrence in infertile women correlated with the degree of androgen suppression.
• Physiological doses of glucocorticoids showed minimal side-effects and allowed for sustained normal androgen levels, even after treatment cessation.

Conclusions:

• Glucocorticoid therapy is an effective treatment for IGSH, addressing both hormonal imbalances and clinical manifestations.
• The treatment corrects the hyperandrogenic state, thereby improving ovulatory function and fertility.
• Long-term management with glucocorticoids is safe and effective for maintaining normal androgen levels indefinitely.